Projects funded by the NCN
MLK4 signaling in DNA damage response and cancer therapy
2021/41/N/NZ3/02997
Keywords:
Kinase MLK4 DNA damage response cancer chemotherapy
Descriptors:
- NZ5_3: Pathogenesis of human diseases
- NZ3_1: Cell biology
- NZ3_7: Signal transduction
Panel:
NZ3 - Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology
Host institution :
Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk
woj.
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 20 - announced on 2021-03-15
Amount awarded: 139 080 PLN
Project start date (Y-m-d): 2022-01-21
Project end date (Y-m-d): 2025-01-20
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- Kinase inhibitors for precision therapy of triple-negative breast cancer: Progress, challenges, and new perspectives on targeting this heterogeneous diseaseAuthors:Dawid Mehlich, Anna A. MarusiakAcademic press:Cancer Letters (rok: 2022, tom: 547, strony: 215775), Wydawca: ElsevierStatus:PublishedDOI:10.1016/j.canlet.2022.215775 - link to the publication